Waverly Advisors LLC Raises Holdings in iShares Biotechnology ETF $IBB

Waverly Advisors LLC increased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 128.6% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 52,515 shares of the financial services provider’s stock after purchasing an additional 29,544 shares during the period. Waverly Advisors LLC’s holdings in iShares Biotechnology ETF were worth $9,988,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Ameritas Advisory Services LLC grew its stake in iShares Biotechnology ETF by 33.1% during the 2nd quarter. Ameritas Advisory Services LLC now owns 5,096 shares of the financial services provider’s stock valued at $969,000 after purchasing an additional 1,268 shares during the last quarter. HB Wealth Management LLC lifted its stake in shares of iShares Biotechnology ETF by 1.9% in the 2nd quarter. HB Wealth Management LLC now owns 4,771 shares of the financial services provider’s stock valued at $907,000 after purchasing an additional 87 shares during the period. Compass Financial Management LLC acquired a new position in shares of iShares Biotechnology ETF in the second quarter worth about $56,000. William John Sempolinski acquired a new position in iShares Biotechnology ETF in the 2nd quarter worth about $260,000. Finally, Timbuktu Capital Management LLC purchased a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at approximately $464,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Down 0.9%

Shares of iShares Biotechnology ETF stock opened at $205.49 on Thursday. The firm’s 50-day moving average price is $199.14 and its 200 day moving average price is $181.02. iShares Biotechnology ETF has a twelve month low of $138.79 and a twelve month high of $217.12.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Monday, June 15th were paid a dividend of $0.0238 per share. This represents a $0.10 annualized dividend and a yield of 0.0%. The ex-dividend date of this dividend was Monday, June 15th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.